Inpatient DM Plan Generator

ADA 2025 AlignedTarget: 140–180 mg/dL
Patient Demographics
Diabetes Status
Home Medications
Complications
RetinopathyNephropathyNeuropathyFoot Ulcers
ASCVD/CADStroke/TIAPADHeart Failure
Dosing Strategy

Use 0.3 for high risk/elderly. Higher for steroid use.

Generated Note

Thank you for your consultation.
We were consulted regarding diabetes management during hospitalization for this — y/o male with T2DM.
He seems to be unclear (based on available information).

Assessment:
• — y/o male, known T2DM.
• Consulted for inpatient glycemic management during admission for: —.
• Current inpatient glucose trend: —.
• Chronic control appears: unclear.
• Microvascular complications: None known.
• Macrovascular complications: None known.

Plan:
1) Diet/monitoring:
• Diabetic diet if no contraindication.
• Target inpatient BG for most patients: **140–180 mg/dL**.
• Check BG AC & HS if eating; if NPO consider Q4–6H monitoring.

2) Medications:
• Hold/avoid **oral/non-insulin agents during acute hospitalization** unless a specific indication and safety profile allow continuation (institution-dependent).
• Home meds (documented): None documented
• Home insulin (documented): None documented

3) Insulin regimen (draft; clinician to confirm):
⚠️ Weight not entered → cannot calculate weight-based insulin dose.

4) Labs / evaluation:
• HbA1c: —%.
• Consider urine ACR / proteinuria assessment if not previously documented (especially if nephropathy suspected).

5) Safety:
• Hypoglycemia protocol:
  - Treat if BG <70 mg/dL (alert level); urgent if <54 mg/dL.
  - If able to take PO: give fast-acting carbohydrate, recheck in 15 min, repeat until ≥70.
  - If NPO/altered: IV dextrose per protocol; consider glucagon if no IV access.
  - Review insulin doses and contributing factors after any hypoglycemia episode.

6) CV risk / statin:
• Lipid/ASCVD prevention (discharge planning):
  - If age 40–75 (most people with diabetes) → at least moderate-intensity statin unless contraindicated.
  - If ASCVD/high risk → high-intensity statin (as tolerated).

7) Follow-up:
• Discharge / follow-up:
  - Ensure home regimen reconciliation + education.
  - Arrange follow-up with PHC / diabetes clinic within 2–4 weeks (earlier if insulin started/changed).
  - Screen/monitor complications (albuminuria, eye exam history, foot care).

References (ADA):
• Inpatient BG target 140–180 mg/dL for most hospitalized patients.
• Hypoglycemia definitions/levels (<70; <54).
• Statin recommendations in ADA Standards (CVD & risk management).
Disclaimer: This tool is for educational/drafting purposes only. Clinician must verify all doses and plans.